Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Interest Expenses (2016 - 2026)

Usana Health Sciences has reported Interest Expenses over the past 16 years, most recently at $240000.0 for Q2 2026.

  • Quarterly Interest Expenses fell 41.61% to $240000.0 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $671000.0 through Apr 2026, up 4.84% year-over-year, with the annual reading at $842000.0 for FY2026, 199.64% up from the prior year.
  • Interest Expenses was $240000.0 for Q2 2026 at Usana Health Sciences, up from $123000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $411000.0 in Q1 2025 and troughed at -$1.6 million in Q1 2022.
  • The 5-year median for Interest Expenses is $50000.0 (2024), against an average of $14388.9.
  • Year-over-year, Interest Expenses tumbled 55.21% in 2023 and then skyrocketed 690.38% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $32000.0 in 2022, then skyrocketed by 353.12% to $145000.0 in 2023, then fell by 11.03% to $129000.0 in 2024, then plummeted by 62.02% to $49000.0 in 2025, then skyrocketed by 389.8% to $240000.0 in 2026.
  • Per Business Quant, the three most recent readings for USNA's Interest Expenses are $240000.0 (Q2 2026), $123000.0 (Q1 2026), and $49000.0 (Q3 2025).